Robert Hershberg

Robert Hershberg

President at HILLEVAX, INC.

Net worth: 2 M $ as of 30/10/2026

63 year
Health Technology
Consumer Services
Finance

Profile

Robert M.
Hershberg
was the founder of VentiRx Pharmaceuticals, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2012 to 2017.
Dr. Hershberg is the founder of HilleVax, Inc., founded in 2020, holding the title of President starting in 2025.
Dr. Hershberg is the founder of Cajal Therapeutics, founded in 2020, serving as Executive Chairman since 2020.
Current jobs include Independent Director at Atai Beckley, Inc. since 2025; Independent Director at Adaptive Biotechnologies Corp.
since 2013; Director at Recursion Pharmaceuticals, Inc. starting in 2026; Director at Beckley Psytech Ltd. since 2024; Director at Danaher Corp.
starting in 2026; Member at UW Medicine; and Senior Advisor at Frazier Management LLC starting in 2026.
Former jobs include Independent Director at NS Wind Down Co., Inc. from 2015 to 2022; Independent Director at Silverback Therapeutics, Inc. from 2017 to 2022; Director at Guide Therapeutics, Inc.; Independent Director at Fate Therapeutics, Inc. from 2020 to 2024; Non-Executive Director at Atai Beckley NV; Vice President-Medical Genetics at Corixa Corp.
from 2001 to 2003; Chief Medical Officer & Senior Vice President at Dendreon Corp.
from 2003 to 2006; Assistant Professor at Harvard Medical School; and Chief Scientific Officer & Executive VP at Celgene Corp.
from 2017 to 2020.
Education includes a doctorate from The Salk Institute for Biological Studies and both undergraduate and doctorate degrees from the University of California, Los Angeles.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/08/2026 46,683 ( 0.03% ) 1 M $ 30/10/2026
05/10/2026 162,156 ( 0.03% ) 653 489 $ 30/10/2026

Robert Hershberg active positions

CompaniesPositionStart
HILLEVAX, INC. President 24/03/2020
ADAPTIVE BIOTECHNOLOGIES CORPORATION Director/Board Member 31/01/2013
RECURSION PHARMACEUTICALS, INC. Director/Board Member 30/10/2026
DANAHER CORPORATION Director/Board Member 08/10/2026
Founder 31/12/2019
Director/Board Member 31/05/2024
Corporate Officer/Principal -
Private Equity Investor 29/02/2020

Former positions of Robert Hershberg

CompaniesPositionEnd
FATE THERAPEUTICS, INC. Director/Board Member 06/06/2024
░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░ ░░░░ ░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Robert Hershberg's experience

Education of Robert Hershberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Robert Hershberg